Elmind Capital LP bought a new stake in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 292,600 shares of the company’s stock, valued at approximately $16,622,606,000. Travere Therapeutics makes up about 4.2% […]